...As another Inception Sciences Inc. company secures an exit, Versant Ventures plans to move away from its build-to-buy... ...away from this model (see “Versant Bites at the Apple” ).
Virginia Li, Assistant Editor
Inception 4 Inc.
Inception Sciences Inc.
Ophthotech...
...Immuno-oncology company Tempest Therapeutics Inc. (San Francisco, Calif.) emerged from Versant Ventures' Inception Sciences Inc. incubator on March...
...Immuno-oncology company Tempest Therapeutics Inc. (San Francisco, Calif.) emerged from Versant Ventures' Inception Sciences Inc. incubator with a...
...As another Inception Sciences Inc. company secures an exit, Versant Ventures plans to move away from its build-to-buy... ...away from this model (see “Versant Bites at the Apple” ).
Virginia Li, Assistant Editor
Inception 4 Inc.
Inception Sciences Inc.
Ophthotech...
...Immuno-oncology company Tempest Therapeutics Inc. (San Francisco, Calif.) emerged from Versant Ventures' Inception Sciences Inc. incubator on March...
...Immuno-oncology company Tempest Therapeutics Inc. (San Francisco, Calif.) emerged from Versant Ventures' Inception Sciences Inc. incubator with a...